Hemorrhoid
Hemorrhoidal disease (HEM) is a prevalent anorectal condition characterized by the symptomatic enlargement and distal displacement of anal cushions.[1] It affects a significant portion of the population globally, often leading to considerable medical and socioeconomic burden.[1]
Biological Basis
Section titled “Biological Basis”Hemorrhoids are thought to arise from the anal cushions, which are normal anatomical structures composed of connective tissue, smooth muscle, and a dense vascular plexus.[1]While traditionally considered a result of lifestyle factors, recent research indicates a genetic predisposition. Studies have demonstrated that HEM is a partly inherited condition, with a detectable heritability estimated at 5% based on SNP data.[1] Genome-wide association studies (GWAS) have identified 102 independent risk loci, collectively explaining approximately 0.9% of HEM heritability.[1]These loci provide novel insights into the pathophysiology, suggesting roles for genes involved in extracellular matrix organization, muscle contraction, and the haemorrhoidal vasculature itself.[1] For instance, certain _ABO_ blood types, specifically type O, have been associated with an increased risk of HEM.[1] Genes like _XKR9_, _ACHE_, and _XKR6_ have also been implicated in blood group antigen encoding related to HEM risk.[1]
Clinical Relevance
Section titled “Clinical Relevance”HEM is a prevalent condition that can significantly impact an individual’s quality of life due to its symptomatic nature.[1] It represents a substantial healthcare cost, with annual expenses in the USA alone estimated at US$800 million, largely attributed to the number of hemorrhoidectomies performed.[1]Furthermore, HEM has been found to have genetic correlations with other health conditions, including diseases of the gastrointestinal, neuroaffective, and cardiovascular domains.[1]Specifically, individuals with HEM often experience higher rates of irritable bowel syndrome (IBS) and other dysmotility syndromes, and there are noted genetic correlations with anxiety and depression.[1] Higher polygenic risk scores for HEM have also been linked to more severe phenotypes, such as the need for recurrent invasive procedures and an earlier age of onset.[1]
Social Importance
Section titled “Social Importance”Despite its widespread distribution and impact, hemorrhoidal disease has historically been regarded as an understudied condition, partly due to its perception as a taboo topic in society.[1]This societal stigma has contributed to a lack of large-scale epidemiological and molecular studies, leaving the full etiology of the disease poorly understood until recently.[1]The disease affects a “silently suffering fraction of the population,” highlighting the need for increased awareness and research to improve understanding, diagnosis, and treatment.[1]
Methodological and Statistical Considerations
Section titled “Methodological and Statistical Considerations”The comprehensive genome-wide association study (GWAS) on hemorrhoidal disease (HEM), while leveraging a large cohort, faces inherent methodological and statistical limitations. The study employed “minimal phenotyping” to achieve its substantial sample size, which, while boosting statistical power, may introduce heterogeneity or imprecision in disease definition, potentially diluting the true genetic signals or leading to the capture of broader disease categories rather than specific HEM subtypes.[1] Despite the large sample, the identified 102 risk loci explain only a small fraction (0.9%) of the estimated 5% SNP-based heritability, highlighting that a substantial portion of HEM’s genetic architecture remains unexplained. This indicates that many genetic factors, possibly with very small individual effects, or more complex genetic interactions, are yet to be discovered.[1] Furthermore, the observation of genomic inflation (λ=1.3) suggests that HEM is a highly polygenic trait, involving numerous genetic variants, each contributing a minute effect. Although linkage disequilibrium score regression analysis (LDSC) attributed this to polygenicity rather than population stratification, the complexity of such a genetic architecture makes comprehensive dissection challenging.[1] The choice of genetic models in GWAS, often assuming additive effects, may also limit the capture of other forms of genetic variation, such as dominant, recessive, or more intricate non-additive interactions, which could contribute to the missing heritability and impact the overall understanding of HEM etiology.[2]
Phenotypic Definition and Remaining Knowledge Gaps
Section titled “Phenotypic Definition and Remaining Knowledge Gaps”The characterization of HEM in large-scale genetic studies often relies on self-reported medical data or broad diagnostic codes, which can introduce variability and potential misclassification in defining cases and controls.[1]This “minimal phenotyping” approach, while enabling large sample sizes, may not adequately capture the clinical heterogeneity of HEM, including varying severity, subtypes, or progression, potentially obscuring more specific genetic associations relevant to particular disease presentations. The broader scientific community also acknowledges HEM as an “understudied disease” with “scarce research” regarding its epidemiology and molecular basis.[1] This limited prior knowledge contributes significantly to remaining gaps in understanding HEM’s genetic architecture and its broader etiology. The modest heritability estimate and the small proportion of variance explained by identified genetic variants underscore that many genetic and non-genetic factors influencing HEM risk are still unknown.[1] A more detailed and standardized clinical phenotyping across diverse populations would be crucial to refine genetic discovery and improve the clinical utility of polygenic risk scores.
Generalizability and Environmental Confounders
Section titled “Generalizability and Environmental Confounders”A significant limitation of the current genetic insights into HEM is their predominant focus on populations of European ancestry.[1]This restricts the direct generalizability of findings, including identified risk loci and polygenic risk scores, to individuals from other ancestral backgrounds, where genetic predispositions, disease prevalence, and environmental exposures may differ substantially.[3] Genetic architecture can vary across populations, necessitating further research in diverse cohorts to ensure equitable understanding and application of genetic risk prediction.
Moreover, complex diseases like HEM are influenced not only by genetics but also by a myriad of environmental factors and gene-environment interactions. The research acknowledges that the etiology of HEM is “unclear” and that “few non-genetic risk factors have been suggested,” pointing to a substantial knowledge deficit regarding the role of lifestyle, diet, socioeconomic status, and other environmental exposures.[1]Without comprehensively accounting for these non-genetic confounders and their interactions with genetic predispositions, the full picture of HEM etiology remains incomplete. Additionally, the inherent biases in large biobank cohorts, such as varying access to healthcare or over-representation of certain conditions, could influence observed disease patterns and severity, further complicating the interpretation of genetic associations across diverse settings.[4]
Variants
Section titled “Variants”Genetic variations play a significant role in an individual’s susceptibility to hemorrhoidal disease, with numerous identified single nucleotide polymorphisms (SNPs) influencing genes involved in diverse biological pathways, from blood group determination to tissue integrity and cellular regulation. Research has revealed that hemorrhoids are a partly inherited condition, with a detectable heritability, and specific genetic loci contribute to this predisposition.[1] These variants can affect the structure and function of blood vessels, connective tissues, and inflammatory responses within the anal canal, contributing to the complex etiology of the condition.
Among the identified genetic factors, variants within the ABO blood group gene are prominent. The ABO gene encodes antigens that determine an individual’s blood type, which are present on the surface of red blood cells and various other cell types, including endothelial cells lining blood vessels. Specific ABO blood types have been associated with varying risks of hemorrhoids; for instance, blood type O has been linked to an increased risk, while types A and B are associated with a decreased risk.[1] This association may stem from the influence of ABOblood groups on coagulation, inflammation, and vascular integrity, which are critical factors in hemorrhoid pathogenesis, as different blood groups can affect the risk of gastrointestinal bleeding and thrombosis.[5] Variants like rs676996 , rs8176746 , and rs587611953 within the ABO locus may modulate the expression or function of these blood group antigens, thereby influencing vascular health and the overall predisposition to hemorrhoids. Additionally, the XKR9gene, which is part of the Kell Blood Group Complex Subunit-Related Family, is also implicated in hemorrhoid risk, with the variantrs1838392 identified in association.[1] While its precise mechanism in hemorrhoids is still being explored, XKR9 is thought to contribute to the complex interplay of blood components and vascular health.
Other genes implicated in hemorrhoid risk include those involved in cellular growth, extracellular matrix organization, and cell cycle regulation. TheHMGA2 gene, for example, is a transcriptional regulator known for its role in cell proliferation, differentiation, and tissue development. Variants such as rs11176001 and rs1383304 in the HMGA2 region may affect its regulatory functions, potentially altering the growth and repair processes of anorectal tissues and contributing to structural abnormalities that predispose to hemorrhoids.[1] Similarly, SMAD3 is a crucial component of the TGF-beta signaling pathway, which is vital for cell growth, differentiation, and the production of extracellular matrix proteins that provide structural support to tissues. The variant rs17293632 in SMAD3could impact this pathway, influencing tissue remodeling, fibrosis, or inflammation, all of which are relevant to the development and progression of hemorrhoidal disease.[1] Furthermore, CDKN2B-AS1 is a long non-coding RNA that regulates genes involved in cell cycle control and has been associated with various vascular conditions, including varicose veins.[2] The variant rs1333047 in this gene may therefore contribute to hemorrhoid risk by affecting cell senescence or the structural integrity of blood vessels and connective tissues in the anal region.
Genes related to metabolism, ion transport, and mucosal integrity also contribute to hemorrhoid susceptibility.GMDS (Guanosine Diphosphate Mannose Synthase) is involved in the synthesis of GDP-mannose, a key precursor for glycosylation, a process essential for the proper function of many proteins and the extracellular matrix. The variant rs722587 in GMDS could affect these glycosylation pathways, potentially impacting the structural integrity of tissues, immune responses, and inflammation in the anorectal area.[1] The ATP1B1gene encodes a subunit of the sodium-potassium pump, a critical enzyme for maintaining cellular ion balance and membrane potential. A variant likers145163454 could alter the function of this pump, affecting smooth muscle contraction, vascular tone, and fluid balance in the hemorrhoidal plexus, thereby influencing venous dilation and hemorrhoid formation.[1] SFMBT1 (Scm-like with four MBTS domains 1) is a gene involved in chromatin remodeling and transcriptional regulation. Variants like rs9847710 might modulate gene expression patterns crucial for tissue development, maintenance, or repair, impacting the overall health and resilience of anorectal tissues. Lastly, MUC12, a mucin gene, plays a role in forming protective mucosal barriers in the gastrointestinal tract. The variant rs4556017 could affect the integrity or function of this mucosal barrier, increasing susceptibility to inflammation, friction-induced damage, or altered tissue responses, which are common features in hemorrhoidal disease.[1] LINC02811, a long intergenic non-coding RNA, with variant rs11585073 , may exert its influence by regulating nearby genes or cellular processes involved in tissue homeostasis or inflammatory responses, contributing to the complex genetic architecture of hemorrhoids.[1]
Key Variants
Section titled “Key Variants”| RS ID | Gene | Related Traits |
|---|---|---|
| rs11176001 rs1383304 | HMGA2 - MIR6074 | bowel opening frequency hemorrhoid vital capacity forced expiratory volume peak expiratory flow |
| rs676996 rs8176746 rs587611953 | ABO | hemorrhoid glycine measurement monocyte count |
| rs1838392 | XKR9 | hemorrhoid |
| rs11585073 | LINC02811 | hemorrhoid |
| rs17293632 | SMAD3 | inflammatory bowel disease ulcerative colitis ankylosing spondylitis, psoriasis, ulcerative colitis, Crohn’s disease, sclerosing cholangitis Crohn’s disease asthma |
| rs722587 | GMDS | BMI-adjusted waist circumference hemorrhoid |
| rs1333047 | CDKN2B-AS1 | pulse pressure measurement hypertension large artery stroke hemorrhoid non-high density lipoprotein cholesterol measurement |
| rs145163454 | ATP1B1 | hemorrhoid venous thromboembolism thrombophilia blood coagulation disease deep vein thrombosis |
| rs9847710 | SFMBT1 | ulcerative colitis gout hemorrhoid urate measurement uric acid measurement |
| rs4556017 | MUC12 | bowel opening frequency hemorrhoid level of carbonic anhydrase 12 in blood serum v-set and immunoglobulin domain-containing protein 2 measurement protein FAM3D measurement |
Definition and Core Terminology
Section titled “Definition and Core Terminology”Hemorrhoid, formally known as Haemorrhoidal disease (HEM), is a prevalent anorectal pathology characterized by the symptomatic enlargement and distal displacement of the anal cushions.[1]These cushions are normal anatomical structures composed of connective tissue, smooth muscle, and a dense vascular network, often referred to as the elaborated haemorrhoidal plexus.[1], [6] This condition affects a significant portion of the population, leading to a considerable medical and socioeconomic burden, including substantial costs primarily associated with surgical interventions.[7]
Pathophysiological Basis and Etiological Frameworks
Section titled “Pathophysiological Basis and Etiological Frameworks”The etiology of hemorrhoids is complex and has historically been poorly understood, with contemporary concepts emphasizing a multifactorial pathophysiology.[1], [8]Recent genome-wide association studies (GWAS) have demonstrated that hemorrhoids are a partly inherited condition, exhibiting a detectable heritability estimated at approximately 5% based on single nucleotide polymorphism (SNP) data.[1]These studies have identified 102 independent genetic risk loci that collectively explain about 0.9% of this heritability, highlighting a genetic component that predisposes individuals to disorders involving smooth muscle, epithelial, and connective tissues.[1]Functional annotation of these genetic loci indicates enrichment in pathways associated with smooth muscle function, epithelial and endothelial development, morphogenesis, extracellular matrix organization, and muscle contraction.[1]Beyond genetic factors, numerous environmental and lifestyle risk factors have been suggested, including a sedentary lifestyle, obesity, reduced dietary fiber intake, prolonged toilet time, straining during defecation, strenuous lifting, constipation, diarrhea, pelvic floor dysfunction, pregnancy, and natural childbirth, although some remain subject to controversy.[1] Specific genetic associations, such as the O blood type, have also been linked to an increased risk of hemorrhoids, while A and B blood types are associated with a decreased risk.[1]
Clinical Classification and Diagnostic Considerations
Section titled “Clinical Classification and Diagnostic Considerations”While comprehensive categorical classification systems for hemorrhoids are not extensively detailed within genetic research, disease severity is clinically assessed and shows correlation with genetic predisposition. For instance, individuals with higher polygenic risk scores (PRS) for hemorrhoids are associated with a more severe phenotype, often indicated by the need for recurrent invasive procedures and a younger age of disease onset.[1]This suggests a dimensional aspect to the disease, where the genetic burden influences both the progression and clinical presentation of symptoms.
In the context of large-scale genetic research, diagnostic and measurement criteria for hemorrhoids frequently rely on “minimal phenotyping” and self-reported medical data to achieve the substantial sample sizes necessary for robust genetic discoveries.[1], [9] These broad approaches enable the identification of genetic risk factors and the calculation of polygenic risk scores, which can then be validated in independent datasets to identify individuals at higher risk.[1]Furthermore, the site-specific localization of selected candidate proteins in anorectal tissues, particularly within haemorrhoidal blood vessels, offers insights into potential biomarkers and diagnostic avenues by highlighting their putative role in the disease’s complex, multifactorial pathogenesis.[1]
Clinical Manifestations and Symptomatic Profile
Section titled “Clinical Manifestations and Symptomatic Profile”Haemorrhoidal disease (HEM) is primarily characterized by the symptomatic enlargement and distal displacement of anal cushions, affecting a significant portion of the population who may experience discomfort silently.[1] Common clinical presentations include symptoms that necessitate medical intervention, with a spectrum of severity that can range to a point requiring recurrent invasive procedures.[1]While specific symptoms like bleeding, pain, or itching are not explicitly detailed in the genetic studies, the term “symptomatic enlargement” implies these types of discomfort. Factors such as constipation, prolonged sitting, and straining during defecation are recognized as associated conditions that can influence the presentation and severity of hemorrhoidal symptoms.[1]
Assessment Approaches and Phenotypic Spectrum
Section titled “Assessment Approaches and Phenotypic Spectrum”The assessment of hemorrhoidal disease often relies on characterizing its symptomatic presentation and the degree of anal cushion enlargement. In large-scale genetic studies, “minimal phenotyping” approaches are utilized to efficiently gather data, frequently drawing from self-reported medical information to identify individuals with HEM.[1] Beyond subjective reports, quantitative measures like polygenic risk scores (PRS) serve as an objective assessment tool, with higher PRS correlating with a more severe phenotype, including a greater likelihood of requiring recurrent invasive procedures and an earlier age of onset.[1] For understanding the underlying biological mechanisms in diseased tissue, research employs advanced methods such as RNA sequencing (RNA-seq) analyses to evaluate gene expression and immunohistochemistry to localize specific proteins within haemorrhoidal tissue.[1]
Variability and Diagnostic Significance
Section titled “Variability and Diagnostic Significance”Hemorrhoidal disease exhibits considerable variability in its presentation, with a younger age of onset being significantly associated with higher polygenic risk scores.[1]This highlights an inter-individual genetic predisposition impacting disease trajectory. From a diagnostic perspective, HEM shows notable genetic correlations with other health conditions, particularly gastrointestinal disorders such as irritable bowel syndrome (IBS) and other dysmotility syndromes.[1]Furthermore, correlations with neuroaffective traits like anxiety and depression have been observed, suggesting potential shared genetic mechanisms, possibly mediated by gut motility.[1] Specific genetic insights, such as the association of ABO blood group (O type with increased risk, A and B types with decreased risk) and variants in the XKR9 gene (rs1838392 ) with HEM risk, provide valuable information for understanding susceptibility, though these are not direct diagnostic tools for acute disease.[1]
Genetic Predisposition and Underlying Molecular Pathways
Section titled “Genetic Predisposition and Underlying Molecular Pathways”Hemorrhoidal disease (HEM) is recognized as a partly inherited condition, with genetic factors playing a role in its etiology. Studies estimate a modest heritability of approximately 5% based on single nucleotide polymorphism (SNP) data.[1]A comprehensive genome-wide analysis identified 102 independent risk loci, which collectively account for about 0.9% of HEM heritability and offer crucial insights into the disease’s pathophysiology.[1] Specific genetic variants, such as those within the ABO blood group locus (rs676996 ) and XKR9 (rs1838392 ), as well as ACHE (rs4556017 ) and XKR6, have been implicated, with O blood type being associated with an increased risk for HEM, while A and B types show a decreased risk.[1] Furthermore, polygenic risk scores (PRS) derived from these genetic markers can help identify individuals at higher risk for HEM, correlating with a younger age of onset and an increased likelihood of requiring recurrent surgical interventions.[1]Functional annotation of these risk loci reveals that the associated genes are significantly enriched in blood vessels and gastrointestinal tissues, and are involved in pathways critical for smooth muscle, epithelial, and endothelial development and morphogenesis.[1] Network transcriptomic analyses have highlighted HEM gene coexpression modules pertinent to the development and integrity of the musculoskeletal and epidermal systems, alongside the organization of the extracellular matrix.[1] Abnormalities in collagen composition, a key component of the extracellular matrix, are also considered to contribute to the pathogenesis of hemorrhoids, impacting the structural integrity of anorectal tissues.[10] These findings underscore a complex polygenic architecture where genetic variants influence the structural and functional components of the anorectal vascular plexus and surrounding tissues.
Lifestyle, Environmental Factors, and Comorbid Influences
Section titled “Lifestyle, Environmental Factors, and Comorbid Influences”Beyond genetic predispositions, a variety of lifestyle and environmental factors are strongly suggested to contribute to the development and progression of hemorrhoids, although some remain controversially reported.[1]Key behavioral factors include a sedentary lifestyle, obesity, and a diet low in dietary fiber, which can lead to constipation.[1] Spending excessive time on the toilet and straining during defecation are direct mechanical stressors on the anal cushions, while strenuous lifting can increase intra-abdominal pressure, further exacerbating the condition.[1]Conditions like chronic constipation or diarrhea, as well as pelvic floor dysfunction, also contribute to the mechanical stress and altered hemodynamics within the anorectal region.[1] Pregnancy and natural childbirth are significant physiological stressors that can lead to the development or worsening of hemorrhoids due to increased pelvic pressure and hormonal changes.[1] The human erect posture is also considered a unique evolutionary risk factor, placing constant gravitational pressure on the anal vasculature.[1] Hemorrhoids also exhibit significant genetic correlation with several other health conditions, pointing to shared underlying mechanisms and gene-environment interactions.[1]Notably, there is a strong correlation with gastrointestinal disorders such as irritable bowel syndrome (IBS) and other dysmotility syndromes, with affected individuals often reporting increased use of medications like laxatives.[1]This suggests that altered gut motility, influenced by both genetic factors and lifestyle, plays a crucial role. Furthermore, correlations with neuroaffective traits like anxiety and depression, and diseases within the cardiovascular and musculoskeletal systems, indicate broader systemic connections.[1]The gut-brain axis, for example, may mediate genetic risk effects through its influence on gut motility, demonstrating how genetic predispositions can interact with environmental triggers and comorbid conditions to impact hemorrhoid susceptibility.[1]
Biological Background of Hemorrhoidal Disease
Section titled “Biological Background of Hemorrhoidal Disease”Hemorrhoidal disease (HEM) is a common anorectal pathology characterized by the symptomatic enlargement and distal displacement of anal cushions.[1] Despite its prevalence, the underlying biological mechanisms and etiology have been historically understudied.[1] Recent large-scale genetic and molecular analyses have begun to shed light on the complex interplay of genetic predisposition, tissue-level alterations, and molecular pathways contributing to its development.[1]
Genetic Predisposition and Regulatory Networks
Section titled “Genetic Predisposition and Regulatory Networks”Hemorrhoidal disease exhibits a detectable genetic component, with a single nucleotide polymorphism (SNP)-based heritability estimated at 5%.[1] Genome-wide association studies (GWAS) have identified 102 independent risk loci, collectively explaining approximately 0.9% of HEM heritability.[1] These loci are functionally annotated based on computational predictions and gene expression analyses performed on both diseased and normal tissues, providing crucial insights into potential causative genes and their regulatory roles.[1] Prioritized candidate genes are often linked to high-confidence fine-mapped variants, show differential expression in affected tissue, are highlighted by pathway enrichment analyses, or function as hub genes within coexpression networks.[1] Gene expression studies in hemorrhoidal tissue, integrating mRNA and microRNA analyses, reveal specific patterns of differential expression and the formation of gene coexpression networks.[1]Significant enrichment has been observed in modules related to ‘extracellular matrix organization’ and ‘muscle contraction,’ underscoring their importance in HEM pathophysiology.[1] For instance, the gene ACHE (rs4556017 ), which encodes acetylcholinesterase, an enzyme critical for hydrolyzing acetylcholine at neuromuscular junctions, is an interesting candidate due to its eQTL association and its known overexpression in conditions affecting gut motility like Hirschsprung’s disease.[1] Additionally, genetic analyses have implicated blood group antigens, specifically the ABO blood group (rs676996 ) and XKR9 (rs1838392 ), with the O blood type being associated with an increased risk of HEM, while A and B types are linked to decreased risk.[1]
Tissue and Cellular Pathophysiology
Section titled “Tissue and Cellular Pathophysiology”Hemorrhoidal disease fundamentally involves the displacement and enlargement of the anal cushions, which are specialized vascular structures in the anal canal.[11] The anorectal vascular plexus plays a central role, with observations suggesting that impaired drainage or filling of these cushions can contribute to their slippage and symptomatic presentation.[6] Histological comparisons across various mammals indicate that the elaborate hemorrhoidal plexus may have evolved in conjunction with permanent bipedalism in humans, highlighting an evolutionary predisposition.[1]At the cellular level, the pathogenesis of HEM involves disruptions in tissue integrity and function, including abnormalities in intestinal and smooth muscle morphology, as well as blood vessel structure.[1] Proteins encoded by HEM-associated genes show diverse expression patterns across intestinal mucosal, neuromuscular, immune, and anodermal tissues, often colocalizing directly with hemorrhoidal blood vessels.[1]This broad localization suggests a complex multifactorial involvement of various cell types and tissue components in the disease process.[1]The critical roles of extracellular matrix (ECM) organization and muscle contraction are further emphasized by their significant enrichment in gene coexpression modules identified in diseased tissue.[1]
Molecular Pathways and Key Biomolecules
Section titled “Molecular Pathways and Key Biomolecules”The molecular mechanisms underlying hemorrhoidal disease involve a range of critical biomolecules and cellular pathways. Key pathways implicated include those governing extracellular matrix (ECM) organization and muscle contraction, which are essential for maintaining the structural integrity and functional dynamics of the anal cushions and surrounding tissues.[1] Specific enzymes, such as acetylcholinesterase encoded by ACHE, play a role in neurotransmitter regulation at neuromuscular junctions, influencing gut motility.[12]Dysregulation of such enzymes can compromise normal physiological processes, contributing to disease development.[1] Receptors and structural components also contribute significantly; for instance, blood group antigens like those determined by the ABO locus are critical biomolecules affecting HEM risk, potentially through their influence on vascular function and coagulation.[13] The O blood type, for example, has been associated with increased HEM risk.[1]Additionally, analyses indicate enrichment in pathways related to ‘abnormal blood vessel morphology’ and ‘abnormal smooth muscle morphology and physiology,’ suggesting that the integrity and function of the vasculature and muscular components are under molecular regulation that can be disrupted in HEM.[1]The interplay of these critical proteins, enzymes, and structural components within regulatory networks is crucial for understanding the complex etiology of hemorrhoidal disease.[1]
Systemic Connections and Gut-Brain Axis
Section titled “Systemic Connections and Gut-Brain Axis”Hemorrhoidal disease is not an isolated condition but shows significant genetic correlations with several other systemic traits and diseases, particularly within the gastrointestinal (GI), neuroaffective, and cardiovascular domains.[14]Patients with HEM frequently experience irritable bowel syndrome (IBS) and other dysmotility syndromes, and these conditions share a strong genetic correlation with HEM, implying similar underlying genetic architectures and predisposing mechanisms.[15]This connection suggests that disruptions in gut motility, potentially influenced by factors like chronic constipation, prolonged straining during defecation, and laxative use, are significant contributors to HEM pathophysiology.[16]The gut-brain axis, a complex bidirectional communication system between the central nervous system and the enteric nervous system, likely mediates some of the genetic risk effects observed in HEM, especially given its strong correlation with anxiety and depression.[15]These neuroaffective traits may influence gut motility and visceral sensation, thereby contributing to or exacerbating HEM symptoms.[15] Furthermore, the strong genetic evidence for the involvement of the vasculature, as highlighted by pathway analyses emphasizing blood vessel and artery morphology, links HEM to broader circulatory system health and potential systemic consequences.[6] The association of ABO blood groups with HEM risk further reinforces these systemic connections, as ABO blood types are known to influence risks of both thrombosis and bleeding.[13]
Vascular and Connective Tissue Dysregulation
Section titled “Vascular and Connective Tissue Dysregulation”Hemorrhoidal disease is fundamentally linked to alterations in the vascular and connective tissues of the anorectal region, evidenced by genetic enrichment in pathways associated with abnormal blood vessel and artery morphology, smooth muscle morphology and physiology, and epithelial and endothelial development.[1]Gene set enrichment analyses highlight processes like ‘tube morphogenesis and development’, ‘artery morphogenesis and development’, ‘epithelium morphogenesis’, and ‘smooth muscle tissue morphogenesis’, suggesting dysregulation in the underlying signaling cascades and transcriptional programs that govern tissue architecture.[1]This dysregulation can lead to impaired venous drainage or filling of the anal cushions, contributing to their prolapse and the characteristic symptoms of the disease.[1] Further support comes from the colocalization of candidate proteins with hemorrhoidal blood vessels, indicating their direct involvement in the local vascular pathology.[1]
Neuromuscular and Motility Pathway Alterations
Section titled “Neuromuscular and Motility Pathway Alterations”Dysfunction in gut motility and neuromuscular control represents a significant pathway in the etiology of hemorrhoidal disease, with patients frequently presenting with irritable bowel syndrome (IBS) and other dysmotility syndromes.[1]Genetic correlations between hemorrhoidal disease and these conditions point to shared predisposing mechanisms, potentially mediated via the gut-brain axis, which influences gastrointestinal function.[1] A key candidate gene, ACHE, which encodes acetylcholinesterase, shows an expression quantitative trait locus (eQTL) for rs4556017 ; ACHEis crucial for hydrolyzing the neurotransmitter acetylcholine at neuromuscular junctions, and its dysregulation can compromise gut motility.[1]Furthermore, proteins encoded by other hemorrhoidal disease-associated genes are expressed within the enteric ganglia adjacent to the hemorrhoidal plexus, suggesting direct involvement in local neuromuscular control and its potential disruption in the disease.[1]
Genetic Regulatory Mechanisms and Network Interactions
Section titled “Genetic Regulatory Mechanisms and Network Interactions”The genetic predisposition to hemorrhoidal disease involves complex regulatory mechanisms, including gene regulation and network interactions that influence tissue integrity and function.[1] Genome-wide analyses have identified numerous risk loci, with differential expression of candidate genes observed in affected hemorrhoidal tissue compared to healthy controls.[1]Transcriptomic studies, integrating mRNA and microRNA data, reveal coexpression networks where specific genes interact in modules (e.g., M1, M4, M7), with module M1 significantly enriched for ‘extracellular matrix (ECM) organization’ and ‘muscle contraction’.[1] This highlights how gene regulatory dysregulation and altered protein expression can collectively impact the structural integrity of the anorectal region and its mechanical properties.
Systemic Factors and Pathway Crosstalk
Section titled “Systemic Factors and Pathway Crosstalk”Hemorrhoidal disease exhibits genetic correlations with a spectrum of conditions across gastrointestinal, neuroaffective, and cardiovascular domains, indicating a broader systems-level integration of predisposing factors.[1] This pathway crosstalk suggests that shared genetic architectures contribute to the susceptibility of multiple seemingly disparate traits, potentially through common underlying biological mechanisms.[1] For instance, the ABO blood group system is implicated, with O type associated with increased risk and A and B types with decreased risk, alongside other blood group complex-related genes like XKR9 (rs1838392 ) and XKR6.[1]These systemic connections underscore the complex, multifactorial etiology of hemorrhoidal disease, extending beyond local anatomical issues to involve widespread physiological processes.
Genetic Susceptibility and Risk Prediction
Section titled “Genetic Susceptibility and Risk Prediction”Hemorrhoidal disease (HEM) is recognized as a partly inherited condition, with a detectable heritability estimated at 5% based on single nucleotide polymorphism (SNP) data. A large genome-wide association study (GWAS) identified 102 independent risk loci, which collectively explain approximately 0.9% of HEM heritability. These genetic findings enable the calculation of polygenic risk scores (PRS), which have been validated in independent datasets to effectively identify individuals at higher risk for HEM.[1]Clinical applications of these PRS extend to predicting disease prognosis, as higher HEM PRS values are associated with a more severe phenotype, indicated by an increased need for recurrent invasive procedures and a younger age of onset.[1] Furthermore, specific genetic variants, such as those determining the ABO blood group, have been linked to HEM risk; genotype data imputation shows that blood group O is associated with an increased risk, while A and B types are associated with a decreased risk.[1] These insights into genetic predisposition and risk stratification pave the way for personalized medicine approaches and targeted prevention strategies.
Systemic Associations and Comorbidities
Section titled “Systemic Associations and Comorbidities”Research has revealed significant genetic correlations between HEM and various other conditions across gastrointestinal, neuroaffective, and cardiovascular domains. Patients with HEM frequently experience irritable bowel syndrome (IBS) and other gut dysmotility syndromes, often leading to increased use of medications like laxatives.[1] These gastrointestinal dysfunctions show the strongest genetic correlation with HEM, suggesting shared genetic architecture and underlying predisposing mechanisms.[1]Beyond the gastrointestinal tract, correlations with neuroaffective traits such as anxiety and depression have been observed, potentially mediating genetic risk effects via mechanisms involving the gut-brain axis and gut motility.[1]Additionally, studies have highlighted an association between hemorrhoids and an increased risk of coronary heart disease.[1] and the ABO blood group, implicated in HEM risk, is also known to be associated with the risk of gastrointestinal bleeding and other health conditions.[5] These findings underscore the importance of considering HEM within a broader systemic context, informing comprehensive patient assessment and management.
Mechanistic Insights and Therapeutic Implications
Section titled “Mechanistic Insights and Therapeutic Implications”Functional annotation of the identified HEM GWAS loci indicates that the associated genes are significantly enriched in blood vessels and gastrointestinal tissues, and participate in pathways crucial for smooth muscle, epithelial, and endothelial development and morphogenesis.[1] Transcriptomic analyses further highlight gene coexpression modules relevant to the integrity of musculoskeletal and epidermal systems, as well as extracellular matrix organization.[1]This suggests that HEM involves a genetic predisposition to dysfunctions in smooth muscle, epithelial, and connective tissues.[1] Site-specific analysis of candidate proteins in anorectal tissues reveals their broad expression in intestinal mucosal, neuromuscular, immune, and anodermal tissues, often colocalizing directly with hemorrhoidal blood vessels.[1]This detailed understanding of the molecular and cellular pathways, including those related to extracellular matrix organization and muscle contraction, provides novel pathophysiological insights into HEM development.[1] These mechanistic discoveries are vital for developing targeted prevention strategies, improving current treatments, and identifying new therapeutic targets for this prevalent condition.
Frequently Asked Questions About Hemorrhoid
Section titled “Frequently Asked Questions About Hemorrhoid”These questions address the most important and specific aspects of hemorrhoid based on current genetic research.
1. My parents have hemorrhoids, will I get them too?
Section titled “1. My parents have hemorrhoids, will I get them too?”Yes, there’s a genetic component to hemorrhoids, meaning they can run in families. While it’s only partly inherited, with about 5% of your risk explained by your genetics, having a family history does increase your chances compared to someone without it. This is due to many small genetic differences you might share.
2. Does my blood type affect my risk of getting hemorrhoids?
Section titled “2. Does my blood type affect my risk of getting hemorrhoids?”Interestingly, yes, research has found a connection between blood type and hemorrhoid risk. Specifically, if you have blood type O, you might have a slightly higher chance of developing hemorrhoids. This is because certain genes, like XKR9, ACHE, and XKR6, involved in blood group antigen encoding, have been linked to hemorrhoid risk.
3. I have IBS, am I more likely to get hemorrhoids?
Section titled “3. I have IBS, am I more likely to get hemorrhoids?”There’s a genetic link between hemorrhoids and other gut issues like Irritable Bowel Syndrome (IBS) and other dysmotility syndromes. So, if you have IBS, you might indeed have a higher genetic predisposition to also experience hemorrhoids. This suggests shared underlying genetic factors influencing your digestive system.
4. Can my anxiety or depression make my hemorrhoids worse?
Section titled “4. Can my anxiety or depression make my hemorrhoids worse?”While anxiety or depression don’t directlycausehemorrhoids, studies have found genetic correlations between hemorrhoidal disease and neuroaffective conditions like anxiety and depression. This means that if you have a genetic predisposition for one, you might also have a higher genetic likelihood for the other, hinting at shared biological pathways.
5. Why did my hemorrhoids start so young, or seem so severe?
Section titled “5. Why did my hemorrhoids start so young, or seem so severe?”Your genetic makeup can play a role in how severe your hemorrhoids become and how early they start. Individuals with higher polygenic risk scores for hemorrhoidal disease tend to experience symptoms at a younger age and may need more frequent or invasive treatments. This indicates a stronger genetic predisposition leads to a more challenging form of the condition.
6. Can eating really well prevent hemorrhoids if they run in my family?
Section titled “6. Can eating really well prevent hemorrhoids if they run in my family?”While genetics do play a role, contributing about 5% to your risk, lifestyle factors like diet and exercise are still very important for managing and potentially preventing hemorrhoids. Even with a family history, focusing on a healthy diet rich in fiber and staying hydrated can significantly help reduce your risk and manage symptoms.
7. Does my non-European background change my hemorrhoid risk?
Section titled “7. Does my non-European background change my hemorrhoid risk?”Most of the current genetic research on hemorrhoids has focused on people of European ancestry. This means that while we know genetics play a role, the specific risk factors and their impact might be different for individuals from other ancestral backgrounds. More research is needed in diverse populations to fully understand these differences.
8. Why do some people never get hemorrhoids, but I keep getting them?
Section titled “8. Why do some people never get hemorrhoids, but I keep getting them?”Part of the reason lies in your individual genetic blueprint. Hemorrhoids are partly an inherited condition, and some people naturally have genetic variations that make them more prone to developing them, even if their lifestyle is similar to others. These genetic differences influence things like your connective tissue and blood vessels.
9. Could a DNA test tell me my risk of developing hemorrhoids?
Section titled “9. Could a DNA test tell me my risk of developing hemorrhoids?”Yes, advanced genetic tests, like those based on Genome-Wide Association Studies (GWAS), can identify your polygenic risk score for hemorrhoids. While these tests can’t predict with 100% certainty, they can indicate if you have a higher genetic predisposition based on the numerous genetic markers associated with the condition.
10. If hemorrhoids run in my family, am I just doomed to get them?
Section titled “10. If hemorrhoids run in my family, am I just doomed to get them?”Not necessarily! While there’s a genetic component to hemorrhoids, it only accounts for about 5% of the risk. This means many other factors, including your lifestyle choices, play a significant role. You can actively reduce your risk and manage symptoms through diet, exercise, and healthy habits, even with a family history.
This FAQ was automatically generated based on current genetic research and may be updated as new information becomes available.
Disclaimer: This information is for educational purposes only and should not be used as a substitute for professional medical advice. Always consult with a healthcare provider for personalized medical guidance.
References
Section titled “References”[1] Zheng T, Ellinghaus D, Juzenas S, et al. “Genome-wide analysis of 944 133 individuals provides insights into the etiology of haemorrhoidal disease.” Gut 2021;70:1538–1549.
[2] Guindo-Martinez M, et al. “The impact of non-additive genetic associations on age-related complex diseases.” Nature Communications, vol. 12, 2021, 2455.
[3] Liu TY, et al. “Diversity and longitudinal records: Genetic architecture of disease associations and polygenic risk in the Taiwanese Han population.”Science Advances, vol. 11, 4 June 2025, eadt0539.
[4] Walters RG, et al. “Genotyping and population characteristics of the China Kadoorie Biobank.” Cell Genomics, vol. 3, 2023, 100378.
[5] Huang ES, Khalili H, Strate LL, et al. “Su1786 ABO blood group and the risk of gastrointestinal bleeding.” Gastroenterology 2012;142:S-503.
[6] Aigner F, Gruber H, Conrad F, et al. Revised morphology and hemodynamics of the anorectal vascular plexus: impact on the course of hemorrhoidal disease. Int J Colorectal Dis 2009;24:105–13.
[7] Yang JY, Peery AF, Lund JL, et al. Burden and cost of outpatient hemorrhoids in the United States Employer-Insured population, 2014. Am J Gastroenterol 2019;114:798–803.
[8] Margetis N. Pathophysiology of internal hemorrhoids. Ann Gastroenterol 2019;32:264–72.
[9] Tung JY, Do CB, Hinds DA, et al. Efficient replication of over 180 genetic associations with self-reported medical data. PLoS One 2011;6:e23473.
[10] Nasseri YY, Krott E, Van Groningen KM, et al. “Abnormalities in collagen composition may contribute to the pathogenesis of hemorrhoids: morphometric analysis.” Tech Coloproctol, vol. 19, 2015, pp. 83–87.
[11] Jacobs, D. “Clinical practice. Hemorrhoids.” New England Journal of Medicine, vol. 371, 2014, pp. 944–51.
[12] Moore, S. W., and G. Johnson. “Acetylcholinesterase in Hirschsprung’s disease.”Pediatric Surgery International, vol. 21, 2005, pp. 255–60.
[13] Franchini, M et al. “Relative risks of thrombosis and bleeding in different ABO blood groups.” Semin Thromb Hemost, 2016.
[14] Chang S-S, Sung F-C, Lin C-L, et al. “Association between hemorrhoid and risk of coronary heart disease: a nationwide population-based cohort study.” Medicine 2017;96:e7662.
[15] Holtmann, G., A. Shah, and M. Morrison. “Pathophysiology of functional gastrointestinal disorders: a holistic overview.” Digestive Diseases, vol. 35, suppl. 1, 2017, pp. 5–13.
[16] Sandler, R. S., and A. F. Peery. “Rethinking what we know about hemorrhoids.” Clinical Gastroenterology and Hepatology, vol. 17, 2019, pp. 8–15.